Infusion Center of New England - Foxboro

12/16/2025

Our office is relocating next month!

Our new home at 18 Washington Street, Foxboro, MA, is almost ready, and we can’t wait for you to see it.

We’re increasing our number of infusion chairs so you can enjoy a more comfortable experience with less waiting. Our physical therapy area is also growing, with more space and updated equipment. And with an expanded research wing and additional provider offices, scheduling will be easier and our team can continue to grow.

We’ll keep sharing updates as we get closer to the move to make sure everything feels smooth and simple for you. In the meantime, feel free to reach out to our team with any questions: neurocenterne.com/contact/.

12/14/2025

Happy !

We hope this season brings joy, hope, and lots of special moments with family, friends, and community. 🕎✨

12/13/2025

Briumvi is an FDA-approved for relapsing forms of multiple sclerosis. It works by targeting CD20-positive B cells. By reducing these cells, Briumvi can help slow disease activity, reduce relapses, and protect the nervous system over time.

Briumvi is typically administered as an intravenous every six months, which allows patients to continue their daily lives while staying on track with treatment.

While Briumvi is not a cure, many people find it helps them maintain stability, manage , and focus on living their lives with greater confidence. If you’re exploring treatment options, call our team at (781) 551-5812, option #4 to learn more about how to begin an infusion referral.

12/11/2025

Ocrevus is an FDA-approved for both relapsing forms of MS and primary progressive MS. It works by targeting a type of immune cell called B cells, which play a role in the damage to the nervous system that occurs in MS. By reducing the activity of these cells, Ocrevus can help slow disease progression, reduce relapses, and protect nerve function over time.

Many patients receive Ocrevus through infusions every six months, which can make managing more convenient. Like all therapies, it can have side effects, so monitoring by a healthcare team is important.

If you’re exploring treatment options, our care team is here to answer questions, explain what to expect, and support you every step of the way. Call us at (781) 551-5812 option #4.

12/08/2025

Here at the Neurology Center of New England, we’re proud to highlight the vital role PT plays in neurological care.

For patients living with conditions like MS, Parkinson’s disease, stroke, neuropathy, and movement disorders, physical therapy can support mobility, balance, strength, coordination, and even promote neuroplasticity. The right therapy can help maintain independence and improve daily function.

We’re proud to offer our patients world class physical therapy care. Our physical therapy treatments range in size and scope, and are always tailored to individual patient needs. If you’d like to explore options, our team is here and accepting referrals: https://bit.ly/4hCx8c4!

12/04/2025

This week at the CTAD conference (Clinical Trials on Alzheimer’s Disease) in San Diego, our team is sharing important real-world perspectives on lecanemab use. By examining how this is being used in everyday clinical practice, we hope to provide valuable that support the Alzheimer’s .

Hear directly from our team in this video, where they discuss key study results and the impact for patients, caregivers, and clinicians: https://bit.ly/3XxG3UE.

11/29/2025

The Neurology Center of New England - Foxboro was proud to have been a clinical research site for an important study, the Fenhance trial.

Dr. Napoli was the Principal Investigator at our site. The results of the Phase 3 trials indicate that investigational fenebrutinib substantially reduced relapses in RMS and delayed progression to disability in PPMS.

These results suggest that fenebrutinib, a strong and selective BTK inhibitor, could become an important new treatment for both forms of MS, addressing ongoing unmet needs.

Learn more about the trial by visiting https://bit.ly/49okyN5.

11/27/2025

Happy ! 🦃

We hope you find time today for all the little things, celebrate with the people who matter most, and create memories that will last a lifetime.

11/26/2025

This November, as we celebrate Epilepsy Awareness Month and the season of , we’re proud to recognize the as a valued .

Epilepsy Alliance America is dedicated to empowering individuals and families affected by epilepsy through education, advocacy, and community support. Their work brings hope, understanding, and strength to so many and we’re grateful for the difference they make.

Learn more or find support at epilepsyallianceamerica.org.

11/23/2025

No, plaque psoriasis isn’t contagious. It’s an immune-mediated condition, meaning the body’s immune system mistakenly triggers rapid skin cell turnover, leading to red, scaly patches.

Here at the Infusion Center of New England, our infusion therapies support patients with plaque psoriasis by managing , reducing inflammation, and improving quality of life.

Understanding the facts helps reduce stigma, supports patients, and encourages those experiencing symptoms to seek .

11/20/2025

Our team will be attending the CTAD Conference (Clinical Trials on Alzheimer’s Disease) in San Diego in early December! We will be presenting important data on the use of Leqembi in our practice.

We look forward to connecting and networking with our clinical, research, and industry partners!

Learn more about the conference here: https://www.ctad-alzheimer.com/.

11/19/2025